The Annals
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 3 August 2004, www.theannals.com, DOI 10.1345/aph.1D182c.
The Annals of Pharmacotherapy: Vol. 38, No. 9, pp. 1543. DOI 10.1345/aph.1D182c
© 2004 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Culbertson, V. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Culbertson, V. L

Comment: drug-related problem classification systems

Vaughn L Culbertson, PharmD

Professor and Chair Department of Pharmacy Practice and Administrative Sciences College of Pharmacy Idaho State University Campus Box 8333 Pocatello, Idaho 83209-8333 fax 208/282-4305 vculb{at}otc.isu.edu

Published Online, August 3, 2004. www.theannals.com, DOI 10.1345/aph.1D182c


TO THE EDITOR: I would like to congratulate van Mil et al.1 for their timely and important discussion of DRP classification systems. I strongly agree that a simple hierarchical system is essential for consistent, accurate, and thorough communication among healthcare providers. However, the authors' search methodology missed at least one additional categorization strategy, which we have successfully utilized in teaching pharmacy students a problem-solving approach to DRPs.2 As originally published,3 our system defined 23 DRPs under 7 diagnostic domains. The taxonomic structure consisted of 6 elements: (i) pharmaceutical diagnostic label, (ii) defining criteria, (iii) mechanism, (iv) primary criteria, (v) pharmacokinetic factors, and (vi) complicating or comorbid conditions.

While we have since revised and continue to refine our system, the intent continues to be to develop a pharmaceutical diagnostic approach that parallels the medical model. In other words, pharmaceutical diagnoses should be based upon a specific etiology in order to define a limited number of potential therapeutic options and/or eliminate irrational interventions that do not address the underlying cause. For the same reason that physicians differentiate chest pain into specific diagnostic etiologies to more appropriately direct therapeutic interventions, so must pharmacists differentiate suboptimal therapy into its relevant patient-specific etiologies. Thus, as implied, this suggests that a differential diagnostic approach can be developed to provide a systematic approach to complicated drug therapy workups, and begins to define a unique set of skills and abilities that differentiates pharmacotherapists from other prescribers.

The authors correctly state "that the optimal DRP classification should lead to one choice of coding only, and therefore should be based on clear definitions." Although we have attempted to provide explicit definitions that dictate only one pharmaceutical diagnosis, it is not a simple task, and likely may require significant energy to accurately define and codify all potential pharmaceutical diagnoses. Nevertheless, the authors have successfully demonstrated the inherent problems associated with current classification systems and established the need for a universal system. Unfortunately, the authors may not have gone far enough in recognizing this critical element in the evolution and transformation of pharmacy from a distribution-oriented to patient-centered focus.

References

  1. van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38: 859-67. DOI 10.1345/aph.1D182[Abstract/Free Full Text]
  2. Hachey D, Lawless CD, Force RW, Culbertson VL. Quantification of pharmaceutical diagnoses in inpatient and outpatient settings (abstract).Meeting Proceedings of the American College of Clinical Pharmacy Spring Practice and Research Forum/International Congress on Clinical Pharmacy , Kansas City, MO: American College of Clinical Pharmacy, April 1999: 385.
  3. Culbertson VL, Larson RA, Cady PS, Kale M, Force RW. A conceptual framework for defining pharmaceutical diagnosis. Am J Pharm Educ 1997;61:12-8.




This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Culbertson, V. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Culbertson, V. L


homecopy help contact us subscription past issues search current issue